MDA/ALS Newsmagazine Vol. 14, No. 7

July-August 2009

Cover Story

The future is bright at the Georgia Institute of Technology’s Healthcare Robotics Lab in Atlanta. Georgia Tech professor and health care robotics researcher Charles Kemp and his team of researchers are working on a project that one day will change the lives of people with disabilities by allowing...

Features

Recently, media outlets reported a possible link between developing ALS and living near Lake Mascoma in Western New Hampshire. The Union Leader in New Hampshire and other news outlets indicated that the risk of developing ALS is “25 times” higher than average for people living around Lake Mascoma, l...
MDA was founded as, and remains today, a grassroots fundraising organization. The overwhelming majority of dollars raised for MDA are through community-driven events. It’s the amazing additive effect of these many local events that make it possible for MDA’s ALS Division to fund quality research and...
It’s a dance, it’s a dip, it’s an … ALS research network? SALSA, MDA’s Southeast ALS Alliance, brought together a piquant blend of nearly 30 professionals from 11 hospitals in the Southeastern United States this May to share information and discuss topics such as ALS clinic management and practices,...
By all accounts, 72-year-old Robert “Bob” Paulson has led an interesting and accomplished life. His is the tale of a Kansas farm boy conquering the Big Apple and creating a beautiful family with whom he’s shared the best life has to offer. Some might say a diagnosis of ALS in 1996 rendered his good...
Gaining access to assistive technology (AT) devices can be an arduous task, especially when funds are low and insurance coverage isn’t available. Equipment loan and recycling programs aid people who want to try out different devices, or who need to borrow equipment while they’re waiting for a device...

Research Roundup

This article presents updates on research, clinical trials and studies in ALS as of June 2009: ceftriaxone, pyrimethamine, tamoxifen, brain-computer interface, gene variants, PLS, spinal cord barriers, ALS Newsmagazine Ceftriaxone trial enters third stage Ceftriaxone, administered...

Advertisements

myMuscleTeam